This open-label, multicenter, single-arm study investigated the efficacy of administration of 20,000 IU of epoetin alfa once every 2 wk as initiation therapy in these patients.

• 这个标签公开，多中心，单一目的的试验观察在起始治疗阶段每两周注射1次重组人红细胞生成素20,000IU的效果。